OKYO Pharma Limited
EMMLF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,970 | -$16,825 | -$13,284 | -$6,218 |
| Dep. & Amort. | $3 | $4 | $4 | $2 |
| Deferred Tax | $0 | $0 | $250 | -$9 |
| Stock-Based Comp. | $735 | $1,120 | $1,274 | $1,719 |
| Change in WC | $3,625 | $2,669 | $4,145 | -$1,024 |
| Other Non-Cash | $1,797 | $3,542 | -$84 | $62 |
| Operating Cash Flow | -$1,811 | -$9,491 | -$7,695 | -$5,468 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | $0 | -$6 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$1 | $0 | -$6 | -$2 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $950 | $0 | $2,000 | $0 |
| Stock Issued | $1,706 | $6,209 | $7,323 | $1,428 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $726 |
| Financing Cash Flow | $2,656 | $6,209 | $9,323 | $2,153 |
| Forex Effect | -$110 | $63 | -$278 | -$872 |
| Net Chg. in Cash | $734 | -$3,219 | $1,345 | -$4,189 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $827 | $4,045 | $2,701 | $6,889 |
| End Cash | $1,561 | $827 | $4,045 | $2,701 |
| Free Cash Flow | -$1,812 | -$9,491 | -$7,701 | -$5,470 |